The biggest stories of the day delivered to your inbox.

Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Researchers have developed a 3D-printed cooling component for liquid-cooled data centers. The Danish Technological Institute and Heatflow, together with Open Engineering from Belgium and Fraunhofer ...

As viaduct construction wraps up, CMRL plans to remove barricades in phases. This means many major roads will soon regain full width, making driving easier and safer while improving traffic flow in ...

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...

Add Yahoo as a preferred source to see more of our stories on Google. Nearly two years after breaking ground, the Catawba Two Kings Casino is taking shape off Interstate 85, about 35 miles from ...

Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...